#chikungunyavaccine

[thenewsfactsnow]

Bharat Biotech Chikungunya Vaccine Development enters Important Phase II/III trial in Costa Rica

.@BharatBiotech, Bharat Biotech and @IVIHeadquarters IVI partnership to advance Chikungunya Vaccine Development - enters Important Phase II/III trial in Costa Rica with first participant getting the jab - #CostaRica #VaccineTrial #ChikungunyaVaccine

Bharat Biotech, and The International Vaccine Institute (IVI) announced today the first participant received Bharat Biotech’s Chikungunya vaccine candidate (BBV87) in a Phase II/III clinical trial in Costa Rica, marking the start of a multi-country study led by IVI in partnership with Bharat Biotech and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the…